# WaveClear Vascular Licenses Resolution Thrombectomy System to Two Chinese Medtech Companies

> partnership · REPORTED · 2026-06-12

WaveClear Vascular announced in June 2026 that it has entered into licensing agreements with two Chinese medical device companies for its Resolution cavitation-based thrombectomy platform, a 6-F catheter-based system for treating peripheral vascular disease. The licensing deals extend the company's commercial reach into the Chinese market.

About WaveClear Vascular: WaveClear Vascular develops the Resolution cavitation thrombectomy system, a catheter-based platform designed to remove blood clots in patients with peripheral vascular disease.

- Company: WaveClear Vascular
- Sector: medical devices
- Primary source: https://evtoday.com/center/limb-salvage

---
Source: MedFuel Intel news monitor. Verification tier: REPORTED. Informational only, not investment advice. Corrections: media@medfuelinc.com.